A phase II multicentre study of irinotecan (CPT 11) in combination with cisplatin (CDDP) in metastatic or locally advanced penile carcinoma (EORTC PROTOCOL 30992) - Theodore, C; Skoneczna, I; Bodrogi, I (Ann Oncol, 2008)
et al.